Analysts Offer Insights on Healthcare Companies: Achieve Life Sciences (ACHV), Aziyo Biologics (ELUT) and Arcadia Biosciences (RKDA)
Buy Rating on Arcadia Biosciences Fueled by Strategic Initiatives and Innovative Product Launches
HC Wainwright & Co. Reiterates Buy on Arcadia Biosciences, Maintains $10 Price Target
Arcadia Biosciences Analyst Ratings
Buy Rating Affirmed for Arcadia Biosciences Amidst Growth and Strategic Shifts
Analysts Have Conflicting Sentiments on These Healthcare Companies: Rain Therapeutics (RAIN), Arcadia Biosciences (RKDA) and Eiger Biopharmaceuticals (EIGR)
HC Wainwright & Co. Maintains Buy on Arcadia Biosciences, Lowers Price Target to $10
Arcadia Biosciences Analyst Ratings
H.C. Wainwright Sticks to Its Buy Rating for Arcadia Biosciences (RKDA)
HC Wainwright & Co. Reiterates Buy on Arcadia Biosciences, Maintains $15 Price Target
Arcadia Biosciences Analyst Ratings
HC Wainwright Adjusts Price Target on Arcadia Biosciences to $15 From $18, Keeps Buy Rating
HC Wainwright & Co. Maintains Buy on Arcadia Biosciences, Lowers Price Target to $15
HC Wainwright & Co. Maintains Buy on Arcadia Biosciences, Raises Price Target to $18
Analysts Offer Insights on Materials Companies: Gold Resource (GORO) and Arcadia Biosciences (RKDA)
Lake Street Adjusts Arcadia Biosciences Price Target to $20 From $80, Maintains Buy Rating
Lake Street Keeps Their Buy Rating on Arcadia Biosciences (RKDA)
No Data